Mononuclear Palladium Complexes Research Articles

Comparative Linkage of Novel Anti-Tumor Pd(II) Complex with Bio-Macromulecules: Fluorescence, UV-Vis, DFT, Molecular Docking and Molecular Dynamics Simulation Studies.

A novel mononuclear palladium complex, [Pd(dach)(SSA)], where dach and SSA are diaminocyclohexane and sulfosalicylic acid ligands, respectively, has been synthesized and identified utilizing analytical and spectral methods. DFT calculations, namely geometry optimization, MEP, HOMO-LUMO and NBO analysis, have been conducted at B3LYP level by aug-ccpVTZ-PP and 6-311G(d, p) basis sets. NBO and HOMO-LUMO analysis exhibited that the palladium compound is stable. MEP showed the potential sites of molecule for the interaction. By employing MTT assay, the cytotoxicity activity of the aforesaid compound was examined on K562 cell line, which revealed a proper activity compared to cisplatin. To ascertain the lipophilicity of the newly made compound, the partition coefficient measurement was accomplished, which follows the order of cisplatin < Pd(II) complex. Next, investigation of binding properties of the studied compound with DNA of calf thymus and BSA were done by spectroscopic (CD, fluorescence emission and electronic adsorption) and non-spectroscopic (viscosity measurements, DNA gel electrophoresis, molecular docking and molecular dynamics simulation) methods. The outcomes of CD and UV-Vis spectroscopy demonstrated that the title compound refolded the protein via increasing the alpha helix percentage. The data obtained from UV-Vis studies indicated the non-intercalative mutual action between Pd(II) complex with DNA. It also revealed that the Kapp magnitude of CT-DNA (7.43 × 104 M- 1) is higher than the BSA (5.17 × 103 M- 1), and L1/2 (midpoint of transition) of CT-DNA (5 µM) is lower than the BSA (5.7 µM), indicating that the complex has a greater binding affinity to CT-DNA than BSA. Fluorescence quenching mechanism of the two biomolecules by the metal complex is static and the calculated thermodynamic parameters (ΔS° < 0 and ΔH° < 0) suggested the hydrogen bonding and/ or van der Waals forces with DNA and BSA. Further, molecular docking indicated that the studied compound fits into the groove of DNA and the site I of BSA. The stability of metal compound-DNA/-BSA in the presence of H2O solvent and over the time were validated via molecular dynamics simulation.

Mononuclear palladium(II) complexes of tridentate S,E,S (E = P, As) pincer ligands

The mononuclear palladium(II) complexes [Pd{PhAs(2-SC6H4)2-κ3S,S’,As}L] (L = PnBu3 (1), PMe2Ph (2)) and [Pd{(Tipp)P(2-SC6H4)2-κ3S,S’,P}(PMe2Ph)] (Tipp = 2,4,6-triisopropylphenyl) (3) bearing tridentate S,E,S (E = P or As) pincer ligands have been prepared and structurally characterised, complexes 1 and 3 also by X-ray diffraction.

Antiproliferative and antimycobacterial effects of mononuclear palladium(II) complexes with N-heterocyclic ligands

A series of mononuclear palladium(II) coordination compounds with N-heterocyclic ligands – 1,10-phenanthroline (phen), pyrazole (Hpz), 3,5-dimethylpyrazole (Hdmpz), and anions of 2-/3-furoic (2-Hfur and 3-Hfur) and trifluoromethanesulfonic (Hotf) acids were obtained. According to the single-crystal X-ray diffraction analysis data in complexes [Pd(Hdmpz)4]·2L (L = 2-fur (1); 3-fur (2)), [Pd(3-fur)2(phen)]·H2O (3) and [Pd(Hpz)2(phen)]·2otf (4), the cation has a square planar environment of N-, O-donor atoms {PdN4} for 1, 2, 4 and {PdN2O2} for 3. The cytotoxic effect of various concentrations of complexes 2, 3 and 4 on human ovarian adenocarcinoma cells (SKOV3) and human dermal fibroblasts (HDF) was measured in vitro. Complex 4 displayed antiproliferative activity against ovarian adenocarcinoma cells, with a six-fold weaker effect on healthy fibroblasts. The antimycobacterial activity of compounds 2–4 was determined in vitro against a non-pathogenic Mycolicibacterium smegmatis strain.

Trinuclear PdII Complexes with a C3 -Symmetric Triethynylbenzene-Based Tris-NHC Ligand: Catalytic Benefits.

A new C3 -symmetric tris-imidazolium tribromide salt 3, featuring 1,3,5-substituted triethynylbenzene, was used for the preparation of a trinuclear PdII pyridine-enhanced precatalyst preparation stabilization and initiation-type (PEPPSI) complex by triple C2 deprotonation followed by the addition of PdCl2 . Trinuclear PdII complex possessing a combination of NHC and PPh3 ligands has also been synthesized. The corresponding mononuclear palladium(II) complexes have also been synthesized for the comparison purpose. All these complexes have been characterized by using NMR spectroscopy and ESI mass spectrometry. The molecular structure of the trinuclear palladium(II) complex bearing mixed carbene and pyridine donor ligands has been established by using single crystal XRD. All the palladium(II) complexes have been used as pre-catalysts, which gave good to excellent yields in intermolecular α-arylation of 1-methyl-2-oxindole and Sonogashira coupling reaction. Catalytic studies indicate an enhanced activity of the trinuclear PdII complex in comparison to the corresponding mononuclear PdII complex for both catalytic transformations. The better performance of the trinuclear complex has also been further supported by preliminary electrochemical measurements. A negative mercury poison test was observed for both the aforementioned catalyses and therefore, it is likely that these organic transformations proceed homogeneously.

Isolation and Characterization of Heteroleptic Mononuclear Palladium(I) Complexes.

Catalytic transformations involving Pd(0)/Pd(II) catalytic cycles are very well known, and processes involving high-valent Pd(III) and Pd(IV) and low-valent Pd(I) intermediates have also gained interest in recent years. Although low-valent Pd(I) intermediates are proposed in these catalytic cycles, isolated and characterized mononuclear Pd(I) species are very rare. Herein, we report the isolation of two heteroleptic mononuclear Pd(I) complexes stabilized by dithiapyridinophane ligands that were fully characterized by single-crystal X-ray diffraction; EPR, IR, UV-vis spectroscopies; and computational studies. Excitingly, one of these Pd(I) complexes shows Kumada Csp3-Csp2 cross-coupling competency, and initial studies of the other shows direct evidence for Csp3-H bond activation proposed to occur at the Pd(I) center.

Synthesis and Solid-State X-ray Structure of the Mononuclear Palladium(II) Complex Based on 1,2,3-Triazole Ligand

Herein, we described the synthesis and X-ray crystal structure of the new [Pd(3)2Cl2] complex with 1,2,3-triazole-based ligand (3). In the unit cell, there are two [Pd(3)2Cl2] molecules, and the asymmetric unit comprised half of this formula due to the presence of an inversion symmetry element at the Pd(II) center. The monoclinic unit cell volume is 1327.85(6) Å3, with crystal parameters of a = 10.7712(2) Å, b = 6.8500(2) Å, and c = 18.2136(6) Å, while β = 98.851(2)°. The structure comprised two trans triazole ligand units coordinated to the Pd(II) ion via one of the N-atoms of the triazole moiety. In addition, the Pd(II) is further coordinated with two trans chloride groups, where each of the trans bonds is equidistant. The crystal structure of the [Pd(3)2Cl2] complex was compared with that for free triazole ligand 3. It was found that the coordinated ligand showed less twist around the C–N bond compared to free triazole ligand 3. The molecular packing of the latter is found controlled by short O…H, N…H, C…N, and C…C interactions in addition to the short Cl…F interhalogen and π–π interactions. H…H (23.5%), Cl…H (14.4%), N…H (14.3%), and O…H (11.2%) are the most dominant contacts. In the [Pd(3)2Cl2] complex, no significant interhalogen or π–π interactions were detected. In this case, Cl…H (31.1%), H…H (16.7%), O…H (11.6%), and F…H (9.7%) are the most dominant contacts.

Platinum (II) and palladium (II) complexes: synthesis, antimicrobial and antifungal activity

The study aims to synthesize and examine the biological activity of mono- and binuclear platinum (II) and palladium (II) complexes containing terminal and bridging nitrite ligands against the test cultures of Bacillus subtilis B4647, Aspergillus brasiliensis (niger) F679, Pseudomonas aeruginosa B8243, and Escherichia coli. Through the interaction of mononuclear platinum (II) and palladium (II) complexes, dimeric complexes having nitrite ligands were synthesized. The composition and structure of these complexes were established using elemental analysis, conductometry, potentiometry, cryoscopy, infrared spectroscopy, X-ray diffraction analysis, and X-ray fluorescence analysis. A way to coordinate nitrite ligands with the central atom was established. Antimicrobial and antifungal properties were evaluated according to the capability of the synthesized complexes to inhibit the activity of bacteria and fungi via diffusion in agar and in vitro dilution. The minimum inhibitory and bactericidal concentrations of the complexes suppressing the visible growth of microorganisms and fungi, as well as exhibiting their bactericidal effect, ranged from 62.5–125 μmol/dm3. The obtained results revealed a high activity of the palladium (II) binuclear complex of the non-electrolytic type and the platinum (II) binuclear complex of the cationic type. Unlike mononuclear complexes, palladium and platinum binuclear complexes demonstrate higher antibacterial activity. Antibacterial effectiveness exhibited by the palladium complex of the non-electrolytic type against bacteria Bacillus subtilis and Escherichia coli, as well as fungi Aspergillus niger, is more pronounced. The only exception is the antimicrobial activity of the palladium complex against Pseudomonas aeruginosa, which is comparable to that of the binuclear platinum complex of the cationic type. By changing the structure of the complex, the composition and charge of the inner sphere, the number of coordination centers, as well as the nature and denticity of ligands, it is possible to achieve a higher toxic effect of the complexes against bacteria and fungi.

Selective Formation of Mononuclear Palladium and Acetonitrile-Bridged Dinuclear Palladium Complexes Containing a Chiral Tridentate Ligand.

From the chiral Schiff base tridentate ligand LPh, unusual acetonitrile-bridged dinuclear palladium complex 1 and organopalladium complex 1' were synthesized selectively by using acetonitrile and ethanol, respectively. The chiral tridentate Schiff base ligand was bound to the palladium metal center with different chelation modes ([ONO] for 1 and [CNO] for 1'). Complex 1 constitutes the first example of dinuclear metal complexes connected only by a bridging acetonitrile, in which an exceptionally short C≡N bond distance [0.945(12) Å] of bridged acetonitrile was observed. To study the influence of a phenyl group attached to an imine, the phenyl-free ligand LH was prepared and used. In that case, an acetonitrile bridge was not observed. Theoretical calculation studies supporting the formation of 1 and 1' are favored.

Catalytic Hydrogenation of Sorbic Acid using Pyrazolyl Palladium(II) and Nickel(II) Complexes as Precatalysts

ABSTRACT We have prepared several pyrazolyl palladium and nickel complexes ([(L1)PdCl2](1), [(L2) PdCl2](2), [(L3) PdCl2](3), [(L1) NiBr2](4), [(L2) NiBr2](5) and [(L3) NiBr2](6)) by reacting 3,5-dimethyMH-pyrazole (L1), 3,5-di-ferf-butyl-1ZÏ-pyrazole (L2) and 5-ferrocenyl-1Zf-pyrazole(L3) with [PdCl2(NCMe)2] or [NiBr2(DME)] to afford mononuclear palladium and nickel complexes, respectively. These complexes were then investigated as pre-catalysts in the hydrogenation of 2,4-hexadienoic acid (sorbic acid). The active catalysts from these complexes demonstrate significant activities under mild experimental conditions. Additionally, the active catalysts show that the hydrogenation of sorbic acid proceeds in a sequential manner, where the less hindered C=C bond (4-hexenoic acid) is preferentially reduced over the more hindered C=C bond (2-hexenoic acid). Keywords: Pyrazolyl catalysts, sorbic acid, hydrogenation, selectivity.

Dimetallic Palladium‐NHC Complexes: Synthesis, Characterization, and Catalytic Application for Direct C−H Arylation Reaction of Heteroaromatics with Aryl Chlorides

AbstractA series of dimetallic palladium(II)‐NHC complexes comprised of 1,4‐naphthalenyl or 9,10‐anthracenyl spacer sandwiched between two imidazole rings was successfully synthesized. These complexes were characterized by 1H and 13C{1H} NMR spectroscopy and elemental analysis. The structures of two dimetallic palladium complexes and a related mononuclear palladium complex to be used for comparative studies were further characterized by X‐ray diffraction. The dimetallic palladium complex with the 9,10‐anthracenyl linker was very efficient in catalyzing direct C−H arylation reactions of heteroaromatic compounds (imidazoles, imidazo[1,2‐a]pyridine, and thioazole) with a broad range of aryl chlorides, employing a mild monopalladium loading of 1.5 mol%. It allows for the effective use of aryl chlorides to prepare arylated heterocycles, previously only accessible with the more reactive bromide counterparts. Importantly, the catalytic activity of the dimetallic precatalyst was found to be higher than that of an analogous mononuclear complex.magnified image

Selective Addition of Palladium on the Rim of Open-Cage Fullerenes To Form Mononuclear and Dinuclear Complexes

Open-cage fullerenes having an 11-membered orifice and keto lactone groups on the rim of the orifice reacted with both Pd(PPh3)4 and Pd(OAc)2/PPh3 to form a mononuclear palladium(0) complex. Two analogous open-cage fullerenes with 18-membered orifices and carbonyl groups on the rim of the orifice reacted under the same conditions to form dinuclear palladium(0) complexes. Three of the products were characterized by single-crystal X-ray diffraction analysis. In all three structures the palladium is coordinated to a fullerene double bond adjacent to a carbonyl group in an η2 pattern. DFT calculations were carried out to explain the high regioselectivity of the coordination reactions.

Antiprotozoal activity of palladium(II) salicylaldiminato thiosemicarbazone complexes on metronidazole resistant Trichomonas vaginalis

Clinical cases of metronidazole resistant Trichomonas vaginalis infections have spurred interest in drug discovery against this protozoal parasite. We have carried out structure-activity studies using mononuclear palladium(II) complexes containing salicylaldiminato thiosemicarbazones on a patient isolate of Trichomonas vaginalis highly resistant to the FDA-approved drug metronidazole. A small library of sixteen compounds were analysed on this resistant isolate. Interestingly, compared with our previous analysis of a metronidazole sensitive strain, susceptibility of this resistant isolate to four of the six most potent compounds was observed. Two compounds had similar IC50 values between the resistant strain and a previously analysed sensitive line. Palladium(II) salicylaldiminato thiosemicarbazone complexes may represent, with further development, a new drug discovery direction for treating clinical cases of metronidazole-resistant T. vaginalis. The most potent compound had an IC50 value of 15 μM on parasite growth and showed no effects on common normal flora bacteria and no morphological effects when tested on cultured mammalian cells.

Para metallation of 3-acetyl-chromen-2-one Schiff bases in tetranuclear palladacycles: focus on their biomolecular interaction and in vitro cytotoxicity

Three tetranuclear (1-3) complexes and a mononuclear (4) palladium(ii) complex were synthesized from 3-acetyl-chromen-2-one Schiff base ligands [H2-3MAC-Rtsc] (where R = H [H2-3MAC-tsc]; CH3[H2-3MAC-mtsc]; C2H5[H2-3MAC-etsc] or C6H5[H2-3MAC-ptsc]) and potassium tetrachloropalladate. Their formation was confirmed by spectroscopic techniques and X-ray crystallographic analysis. Their ability to bind with DNA and albumin was analysed by using absorption and emission titrations. The MTT assay was carried out to analyze the anticancer potential of the ligands and synthesized complexes against HepG2 (human liver cancer) and HT-29 (human colon cancer) cells. In addition, the compounds were less toxic when tested against the human normal keratinocyte cells (HaCaT). Ligands and complexes displayed better cytotoxicity with lower IC50 values than the standard drug cisplatin. Further AO-EB and DAPI staining assays were carried out to detect the mode of cell death induced by the complexes i.e. apoptosis or necrosis. The complex 3 showed better cytotoxicity and was further subjected to flow cytometric analysis. The results suggested that the complex 3 induced apoptotic cell death.

Synthesis and palladium(II) metal chemistry of thiazoline/imidazoline derived ligands: An efficient catalyst for cross-coupling reactions of arylboronic acids with acid chlorides and aryl halides

The synthesis, reactivity, spectroscopic characterization and catalytic activities of a series of Pd(II) complexes bearing the chelating ligands 2-(4,5-dihydrothiazol-2-yl)aniline (2) and 2-(4,5-dihydro-1H-imidazol-2-yl)aniline (3) are reported. The reactions of 2 with [Pd(COD)Cl2] in 1:1 and 1:2 (ligand into metal and metal into ligand) molar ratios afforded the mononuclear complexes, PdCl2{κ2−N,S − 2−(4,5-dihydrothiazol-2-yl)aniline} (4), Pd{κ2−N,N’−2−(4,5-dihydrothiazol-2-yl)aniline}2 (5) and Pd{κ12−N,N’−κ22−N,S − 2−(4,5-dihydrothiazol-2-yl)aniline}2 (6), respectively, in good yields. The neutral mononuclear palladium complexes PdCl2{κ2−N,N’−(4,5-dihydro-1H-imidazol-2-yl)aniline} (7) and Pd{κ2−N,N’−2−(4,5-dihydro-1H-imidazol-2-yl)aniline}2 (8) were synthesized using [Pd(COD)Cl2] with appropriate molar ratios. The palladium complexes 4–8 were evaluated for their catalytic activities in base assisted cross coupling reactions between acid chlorides and aryl halide with boronic acids. The complex 4 was found to be an efficient catalyst for producing unsymmetrical ketones (TOF = 19.8 min−1) while complex 7 was effective for making biaryls (TOF = 19.8 min−1).

Synthesis, spectral, structural characterization and biological activity of new palladium(II) complexes containing 3‐acetyl‐8‐methoxy‐2H‐chromen‐2‐one derived Schiff bases

Four different mononuclear palladium(II) complexes of 3‐acetyl‐8‐methoxycoumarin Schiff bases were synthesized and characterized by spectrochemical techniques. Further analysis through X‐ray crystallography confirmed the structures of the complexes. Their interactive ability with Calf Thymus DNA and protein (Bovine Serum Albumin and Human Serum Albumin) were investigated by means of absorption and emission methods. The intercalative mode of binding with DNA was supported by EB displacement studies and viscosity measurements. Configurational changes that occurred in the proteins have been analysed with the help of 3D fluorescence studies. The complexes were shown to have good antimicrobial activity against the tested bacterial and fungal pathogens. In addition, antiproliferative activity of the complexes was evaluated on A549 and MCF‐7 cell lines and the complexes were comparatively more active than the standard drug cisplatin. Among the compounds, complex 3 was the most effective against MCF‐7 (IC50 value of 5.20 ± 0.15 μM) and A549 (5.09 ± 0.13 μM) compared with the other complexes 1 (6.48 ± 0.17 μM; 5.98 ± 0.09 μM), 2 (5.53 ± 0.12 μM; 5.85 ± 0.11 μM), 4 (6.73 ± 0.19 μM; 6.63 ± 0.16 μM) and cisplatin (16.79 ± 0.08 μM; 15.10 ± 0.05 μM) respectively. LDH and NO release assays confirmed the cytotoxic potential of the synthesized complexes.

Isolation of a bis(silyl)palladium complex and Si–Si bond formation on a mononuclear palladium complex

Treatment of a chelating silane 1-(dimethylsilyl)-2-silylbenzene (4) with Pd(PEt3)4 in the ratio of 2:1 selectively afforded a unique mononuclear palladium complex [{1,2-C6H4(SiMe2)(SiH)}2Pd(PEt3)2] (6), which was formed by two Si–Si coupling reactions between the SiH2 groups and the SiMe2 moieties from two hydrosilane ligands. Complex 6 was structurally characterized by single crystal X-ray analysis and multinuclear NMR spectroscopic studies and is one of the very few examples of cis-bis(silyl)palladium(II) complexes containing in situ formed Si–Si single bonds.

Influence of the Metal Ion on the Electrocatalytic Hydrogen Production by a Thiosemicarbazone Palladium Complex

We describe the synthesis and characterization of a new mononuclear palladium complex (PdL) based on a thiosemicarbazone ligand. X‐ray diffraction data collected on single crystals reveal that the complex is a neutral mononuclear entity with symmetric square‐planar geometry around the metal center. The complex exhibits an electrocatalytic behavior for proton reduction in DMF solvent using trifluoroacetic acid (TFA) as a proton source. Gas analysis under controlled electrocatalytic conditions during 4 h at a pool mercury working electrode showed a moderate production of dihydrogen. By combining experimental techniques to theoretical calculations, the results are analyzed and compared to those obtained for the previously reported NiL complex in an effort to rationalize the influence of the metal center on the catalytic performance of PdL to mediate hydrogen evolution.

Synthesis and characterization of four novel palladium(II) and platinum(II) complexes with 1-(2-aminoethyl)pyrrolidine, diclofenac and mefenamic acid: In vitro effect of these complexes on human serum paraoxanase1 activity.

In this study, the effects of four novel mononuclear palladium(II) and platinum(II) complexes on the activity of human serum paraoxanase1 were examined. First, four novel mononuclear palladium(II) and platinum(II) complexes were synthesized with a nitrogen donor ligand 1-(2-aminoethyl)pyrrolidine and nonsteroidal anti-inflammatory drugs diclofenac, mefenamic acid. These complexes were characterized by spectroscopic, thermal, and elemental analyses. The crystal structures of complex [Pd(2-amepyr)2 ](dicl)2 1 and [Pd(2-amepyr)2 ](mef)2 3 were determined by X-ray crystallography. Then, paraoxonase1 enzyme was purified from human serum. The effects of these complexes on enzyme were evaluated in vitro. The complexes consist of the cationic unit and the counterions. The diclofenac and mefenamic acid acted as a counterion in the complexes. It was observed that all the complexes were stable up to high temperatures. These complexes, even at low doses, inhibited the activity of the enzyme with different inhibition mechanisms.

Synthesis and spectroscopic characterization study of new palladium complexes containing bioactive O,O-chelated ligands: evaluation of the DNA/protein BSA interaction, in vitro antitumoural activity and molecular docking

[Pd{(C,N)–C6H4CH2NH(Et) (Qu)] (2) and [Pd{(C,N)–C6H4CH2NH(Et) (Nar)] (3) (Qu = Quercetin, Nar = Naringin) mononuclear palladium (II) complexes have been synthesized and characterized using elemental analysis, IR and electronic spectroscopy. The interaction of the prepared complexes with calf thymus DNA and bovine serum albumin (BSA), monitored by UV–visible and fluorescence titrations, respectively, have been carried out to better understand the mode of their action under biological conditions. Intercalative binding mode between the complexes and DNA is suggested by the binding constant (Kb) values of 2.5 × 106 and 3.2 × 106 for complexes 2 and 3, respectively. In particular, the in vitro cytotoxicity of the complexes on two cancer cells lines (bladder carcinoma TCC and breast cancer MCF7) showed that the compounds had broad spectrum, anti-cancer activity with low IC50 values and the order of in vitro anticancer activities is consistent with the DNA-binding affinities. In the meantime, the quenching of tryptophan emission with the addition of complexes using BSA as a model protein indicated the protein binding ability. The quenching mechanisms of BSA by the complexes were static processes, according to the results obtained. The competitive binding using Warfarin, Digoxin and Ibuprofen site markers, which contain definite biding sites, demonstrated that the complexes bind to site I on BSA. Ultimately, the binding sites of DNA and BSA with the complexes have been determined by molecular modelling studies.

Benzylamine-K2-C,N]1,2-Bis (Diphenylphosphino)-Propane-k2-P,P] Palladium}Perchlorate, Mononuclear Complex of Ortho-Palladated Derived from Benzylamine

This work reports the preparation of the mononuclear derivative [Pd(C6H4CH2NH2) L](ClO4) (L = dppp). The centrosymmetric mononuclear palladium complex obtained by the reaction of palladium(II) acetate with benzylamine in toluene produced the acetate cyclopalladated dimer of benzylamine. Metathesis reaction of this acetate-bridged cyclopalladated complex with NaCl in water and acetone gave N,C-orthopalladated [Pd(C6H4CH2NH2)(µ-Cl)]2 complex, which reacts with NaClO4/dppp to give the mononuclear derivative. The ortho-palladation complex was characterized by various spectroscopic techniques such as elemental analysis, IR, 1H, 31P, and 13C NMR. The structures of N,C-metalated complex 3 were determined by X-ray diffraction study.